#drug-pricing

[ follow ]
#obesity

Novo Nordisk sells hit weight-loss drug in China-at fraction of US price

Wegovy's price in China is substantially lower than in the US, highlighting global disparities in drug pricing.

Elon Musk and Bernie Sanders say they agree on one thing-cheaper Ozempic

The U.S. healthcare system's failures unite unlikely political allies like Elon Musk and Bernie Sanders in the fight for affordable medication.

Novo Nordisk sells hit weight-loss drug in China-at fraction of US price

Wegovy's price in China is substantially lower than in the US, highlighting global disparities in drug pricing.

Elon Musk and Bernie Sanders say they agree on one thing-cheaper Ozempic

The U.S. healthcare system's failures unite unlikely political allies like Elon Musk and Bernie Sanders in the fight for affordable medication.
moreobesity
#biden-administration

Medicare drug price negotiations: Here's a savings breakdown

Medicare recipients will save $1.5 billion on medication costs starting in 2026 through negotiated drug prices.

Biden administration announces prices for 10 drugs in Medicare negotiations that will save $6 billion

Medicare's new drug price negotiations will provide significant savings for older adults, impacting 10 commonly used and expensive medications.

Drugs to treat diabetes, heart disease and blood cancers among those affected by price negotiations

Medicare negotiation will save recipients $1.5 billion on medications starting in 2026.

Joe Biden and Bernie Sanders Demands Drug Companies Cut Price of Ozempic and Other New Weight Loss Drugs

Biden and Sanders urge Novo Nordisk and Eli Lilly to lower prices of weight loss drugs for American patients.

Medicare drug price negotiations will save Americans billions, but some concerns remain

The Biden administration announced significant drug price negotiations under Medicare, but actual savings and system impact may take time to realize.

Future of Medicare drug price negotiations murky under Trump

The future of Medicare drug price negotiation under Biden faces uncertain prospects with the incoming Congress's Republican control.

Medicare drug price negotiations: Here's a savings breakdown

Medicare recipients will save $1.5 billion on medication costs starting in 2026 through negotiated drug prices.

Biden administration announces prices for 10 drugs in Medicare negotiations that will save $6 billion

Medicare's new drug price negotiations will provide significant savings for older adults, impacting 10 commonly used and expensive medications.

Drugs to treat diabetes, heart disease and blood cancers among those affected by price negotiations

Medicare negotiation will save recipients $1.5 billion on medications starting in 2026.

Joe Biden and Bernie Sanders Demands Drug Companies Cut Price of Ozempic and Other New Weight Loss Drugs

Biden and Sanders urge Novo Nordisk and Eli Lilly to lower prices of weight loss drugs for American patients.

Medicare drug price negotiations will save Americans billions, but some concerns remain

The Biden administration announced significant drug price negotiations under Medicare, but actual savings and system impact may take time to realize.

Future of Medicare drug price negotiations murky under Trump

The future of Medicare drug price negotiation under Biden faces uncertain prospects with the incoming Congress's Republican control.
morebiden-administration
#healthcare-policy

Here's where Harris and Trump stand on three big health care issues

The upcoming election could dramatically influence healthcare policy affecting millions of Americans.
Two-thirds of Americans believe healthcare deserves more focus in the election discussions.

Politicians' proposals would only minimally lower US drug prices, says report

Most popular drug pricing proposals may only slightly reduce costs; systemic change is needed.
Single policy won't suffice—multiple strategies necessary to control drug prices.

Ozempic very likely' to see prices slashed in drug price negotiations

Ozempic is likely to be included in upcoming drug price negotiations with the US government.

Ozempic 'very likely' to have price slashed

Ozempic is expected to be included in upcoming negotiations for price reductions under the US government's new drug pricing policies.

Here's where Harris and Trump stand on three big health care issues

The upcoming election could dramatically influence healthcare policy affecting millions of Americans.
Two-thirds of Americans believe healthcare deserves more focus in the election discussions.

Politicians' proposals would only minimally lower US drug prices, says report

Most popular drug pricing proposals may only slightly reduce costs; systemic change is needed.
Single policy won't suffice—multiple strategies necessary to control drug prices.

Ozempic very likely' to see prices slashed in drug price negotiations

Ozempic is likely to be included in upcoming drug price negotiations with the US government.

Ozempic 'very likely' to have price slashed

Ozempic is expected to be included in upcoming negotiations for price reductions under the US government's new drug pricing policies.
morehealthcare-policy
#inflation-reduction-act

How Health Care Affordability and Access Could Change under Harris or Trump

Candidates Harris and Trump plan to tackle U.S. health care issues but propose vastly different policies affecting drug costs and access to care.

As Harris and Biden Take a Victory Lap on Drug Costs, She Sets the Pace

Biden and Harris emphasize a united front while celebrating accomplishments like lowering drug costs, showcasing leadership and legacy.

Pharma Companies' Challenge to Inflation Reduction Act Heats Up

The IRA aims to lower drug prices but faces constitutional challenges from pharmaceutical companies over pricing and First and Fifth Amendment rights.

How Health Care Affordability and Access Could Change under Harris or Trump

Candidates Harris and Trump plan to tackle U.S. health care issues but propose vastly different policies affecting drug costs and access to care.

As Harris and Biden Take a Victory Lap on Drug Costs, She Sets the Pace

Biden and Harris emphasize a united front while celebrating accomplishments like lowering drug costs, showcasing leadership and legacy.

Pharma Companies' Challenge to Inflation Reduction Act Heats Up

The IRA aims to lower drug prices but faces constitutional challenges from pharmaceutical companies over pricing and First and Fifth Amendment rights.
moreinflation-reduction-act
#medicare

Medicare costs significantly lowered on popular prescription drugs for cancer, diabetes, heart disease and arthritis

Medicare drug negotiations will significantly lower the cost of 10 high-cost drugs for enrollees, saving billions in coming years.

Big-name drugs see price drops in first round of Medicare negotiations

Medicare's first direct negotiations resulted in significant price cuts on essential drugs, promising substantial savings for both the program and beneficiaries.

On Drug Prices, Harris Pushes for Deeper Cuts While Trump Offers Few Specifics

Drug pricing reforms may hinge on the outcome of the upcoming election.
Kamala Harris aims to expand drug negotiation policies and fund long-term care through savings.
Trump's approach to drug pricing is uncertain, having changed his stance on key issues.

Investors shrug off drug price talks' effects

Pharmaceutical companies interpret negotiated drug prices as manageable, influencing future drug development despite initial fears of drastic changes.

Medicare costs significantly lowered on popular prescription drugs for cancer, diabetes, heart disease and arthritis

Medicare drug negotiations will significantly lower the cost of 10 high-cost drugs for enrollees, saving billions in coming years.

Big-name drugs see price drops in first round of Medicare negotiations

Medicare's first direct negotiations resulted in significant price cuts on essential drugs, promising substantial savings for both the program and beneficiaries.

On Drug Prices, Harris Pushes for Deeper Cuts While Trump Offers Few Specifics

Drug pricing reforms may hinge on the outcome of the upcoming election.
Kamala Harris aims to expand drug negotiation policies and fund long-term care through savings.
Trump's approach to drug pricing is uncertain, having changed his stance on key issues.

Investors shrug off drug price talks' effects

Pharmaceutical companies interpret negotiated drug prices as manageable, influencing future drug development despite initial fears of drastic changes.
moremedicare
#uspto

Why the Proposed Rule on Terminal Disclaimers Should Not Be Finalized

The USPTO should enhance examination practices for continuation applications while leaving policy decisions about patent thickets to Congress.

Chamber's GIPC Tells USPTO to Pivot on Coordination Plans with FDA

Activists are urging the FDA to engage more in patent examination processes, but this initiative faces opposition from the U.S. Chamber of Commerce.

Why are the FDA and USPTO Ignoring Requests for Info on I-MAK?

Senator Tillis questions FDA and USPTO on data supporting drug pricing proposals, emphasizes need for accurate information.

Why the Proposed Rule on Terminal Disclaimers Should Not Be Finalized

The USPTO should enhance examination practices for continuation applications while leaving policy decisions about patent thickets to Congress.

Chamber's GIPC Tells USPTO to Pivot on Coordination Plans with FDA

Activists are urging the FDA to engage more in patent examination processes, but this initiative faces opposition from the U.S. Chamber of Commerce.

Why are the FDA and USPTO Ignoring Requests for Info on I-MAK?

Senator Tillis questions FDA and USPTO on data supporting drug pricing proposals, emphasizes need for accurate information.
moreuspto
#novo-nordisk

'Stop ripping us off': Ozempic producer CEO in hot seat in congressional hearing

The U.S. pays significantly higher prices for Ozempic and Wegovy compared to other countries, prompting scrutiny from Senate leaders.

Bernie Sanders grills Ozempic maker over high prices

Novo Nordisk CEO faced scrutiny in Congress over drug pricing and its moral implications for patients, especially in relation to high prices and access to medication.

Chamber, MSF Weigh in on Senate HELP Committee Hearing with Novo Nordisk CEO

The U.S. Chamber opposes price controls, claiming they hinder innovation and access to medications amid scrutiny of rising drug prices.

'Stop ripping us off': Ozempic producer CEO in hot seat in congressional hearing

The U.S. pays significantly higher prices for Ozempic and Wegovy compared to other countries, prompting scrutiny from Senate leaders.

Bernie Sanders grills Ozempic maker over high prices

Novo Nordisk CEO faced scrutiny in Congress over drug pricing and its moral implications for patients, especially in relation to high prices and access to medication.

Chamber, MSF Weigh in on Senate HELP Committee Hearing with Novo Nordisk CEO

The U.S. Chamber opposes price controls, claiming they hinder innovation and access to medications amid scrutiny of rising drug prices.
morenovo-nordisk

Ozempic producer CEO in hot seat in Senate hearing over cost of weight loss drug

High prices for diabetes and obesity drugs like Ozempic are jeopardizing patient access, especially among low-income and minority groups.
#pharmacy-benefit-managers

FTC goes after drug middlemen for allegedly jacking up insulin prices

The FTC is suing three PBMs for allegedly inflating insulin prices, impacting many Americans reliant on the drug.

Drug middlemen illegally drive up the cost of insulin, FTC says

Federal regulators accuse major pharmacy benefit managers of driving up insulin costs and limiting access to cheaper versions, impacting millions of diabetes patients.

LETTER: Congress should launch immediate reforms of Pharmacy Benefit Managers

Affordability in healthcare is critically impacted by Pharmacy Benefit Managers' control over drug pricing.

The FTC Released a Scathing Interim Report on PBMs. What's Next? - MedCity News

The FTC's investigation on PBMs reveals market concentration and profit generation issues, impacting drug costs and independent pharmacies negatively.

Big Pharma spends billions more on executives and stockholders than on R&D

Pharmaceutical companies spend more on executive compensation and stock buyouts than on research and development for new drugs.
Pharmacy benefit managers (PBMs) contribute to drug pricing but their profits pale in comparison to pharmaceutical profits.

FTC says prescription middlemen are squeezing Main Street pharmacies

Prescription drug middlemen, known as PBMs, inflate drug prices, overcharge cancer patients, and squeeze independent pharmacies, impacting accessibility, cost, and care for Americans.

FTC goes after drug middlemen for allegedly jacking up insulin prices

The FTC is suing three PBMs for allegedly inflating insulin prices, impacting many Americans reliant on the drug.

Drug middlemen illegally drive up the cost of insulin, FTC says

Federal regulators accuse major pharmacy benefit managers of driving up insulin costs and limiting access to cheaper versions, impacting millions of diabetes patients.

LETTER: Congress should launch immediate reforms of Pharmacy Benefit Managers

Affordability in healthcare is critically impacted by Pharmacy Benefit Managers' control over drug pricing.

The FTC Released a Scathing Interim Report on PBMs. What's Next? - MedCity News

The FTC's investigation on PBMs reveals market concentration and profit generation issues, impacting drug costs and independent pharmacies negatively.

Big Pharma spends billions more on executives and stockholders than on R&D

Pharmaceutical companies spend more on executive compensation and stock buyouts than on research and development for new drugs.
Pharmacy benefit managers (PBMs) contribute to drug pricing but their profits pale in comparison to pharmaceutical profits.

FTC says prescription middlemen are squeezing Main Street pharmacies

Prescription drug middlemen, known as PBMs, inflate drug prices, overcharge cancer patients, and squeeze independent pharmacies, impacting accessibility, cost, and care for Americans.
morepharmacy-benefit-managers

How the Vice Presidential Candidates Compare on Health Care

Tim Walz's selection by Vice President Harris emphasizes health care as a crucial issue in the November presidential election.

HIV vaccine' could be made for just $40 a year for every patient

Lenacapavir, a new drug, could revolutionize HIV prevention if available affordably globally, priced at $40 a year instead of $42,250 currently.

C4IP Urges Senate Judiciary to Ignore Common Myths About Drug Patents

'Evergreening' and 'patent thicketing' aren't a barrier to cheaper generics.

California joining with New Jersey company to make generic opioid overdose reversal drug

California to sell generic Narcan to combat opioid overdose at a cheaper rate and aims to distribute it broadly.

Senators ask CEOs why their drugs cost so much more in the U.S.

Sen. Bernie Sanders questioned drug company executives about high drug prices in the U.S.
Drug prices in the U.S. are significantly higher compared to other countries.
#senate-health-committee

Under Bernie Sanders's Glare, Pharmaceutical Chiefs Will Testify on Drug Prices

The chief executives of Johnson & Johnson, Merck, and Bristol Myers Squibb are set to testify in front of the Senate health committee regarding drug pricing in the US.
Senator Bernie Sanders plans to focus the hearing on why drug prices are higher in the US compared to other wealthy countries.
The hearing coincides with the launch of a new federal program that authorizes Medicare to negotiate the prices of some costly medications.

Under Bernie Sanders' glare, pharmaceutical chiefs will testify on drug prices

CEOs of three major pharmaceutical companies to testify before Senate health committee on drug pricing in the US.
The executives are expected to clash with committee chair Bernie Sanders over high drug prices in comparison to other countries.

Under Bernie Sanders's Glare, Pharmaceutical Chiefs Will Testify on Drug Prices

The chief executives of Johnson & Johnson, Merck, and Bristol Myers Squibb are set to testify in front of the Senate health committee regarding drug pricing in the US.
Senator Bernie Sanders plans to focus the hearing on why drug prices are higher in the US compared to other wealthy countries.
The hearing coincides with the launch of a new federal program that authorizes Medicare to negotiate the prices of some costly medications.

Under Bernie Sanders' glare, pharmaceutical chiefs will testify on drug prices

CEOs of three major pharmaceutical companies to testify before Senate health committee on drug pricing in the US.
The executives are expected to clash with committee chair Bernie Sanders over high drug prices in comparison to other countries.
moresenate-health-committee

CVS announces plan to revamp how much drugs cost

CVS Health plans to overhaul its drug payment model to increase transparency and potentially lower drug prices.
The new model will be based on how much CVS pays for drugs, plus a markup and set fee, and will come into effect in 2025.
[ Load more ]